TCMBANKIN000383 |
Euphol |
CHEMBL465181; (3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; ST24047202; AIDS-064689; ZINC4097719; FT-0698509; AIDS064689; CHEBI:4940; AKOS016010616; Euphol (6CI); AC1L9BGD; (3S,5R,10S,13S,14S)-17-((R)-1,5-Dimethyl-hex-4-enyl)-4,4,10,13,14-pentamethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; SCHEMBL541497; BG01135940; (20R)-(+)-triucalla-8,24-diene-3beta-ol; AK120346; euphol; (3S,5R,10S,13S,14S,17S)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3beta,13alpha,14beta,17alpha)-Lanosta-8,24-dien-3-ol; Lanosta-8,24-dien-3-ol, (3.beta.,13.alpha.,14.beta.,17.alpha.)-; Euphadienol; (+)-Euphol; (s)-euphol; (+)-alpha-Euphol; AJ-48007; alpha-Euphol; Eupha-8,24-dienol; C08624; 514-47-6; LMPR0106090002; KB-277032; 13alpha,14beta,17betaH-Lanosta-8,24-dien-3beta-ol (8CI); 7162AB |
C30H50O |
426.72 |
CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
TCMBANKIN026073 |
glutinic acid |
glutinicacid |
C5H4O4 |
128.08 g/mol |
C(=CC(=O)O)[CH+]C(=O)[O-] |
TCMBANKIN036814 |
β-Amyrin |
SCHEMBL14226156; beta-Amyrine; β- amyrin; beta-amyrin ; beta-amyrin; 12-oleanex-3beta-ol; NSC-527971 |
|
426.72 |
|
TCMBANKIN037089 |
Euphorbetin |
35897-99-5; 5-(6,7-dihydroxy-2-oxochromen-5-yl)-6,7-dihydroxychromen-2-one; AC1NSVDP; 5-(6,7-dihydroxy-2-oxo-5-chromenyl)-6,7-dihydroxy-2-chromenone; euphorbetin; 5-(6,7-dihydroxy-2-oxo-chromen-5-yl)-6,7-dihydroxy-chromen-2-one; 5-(6,7-dihydroxy-2-keto-chromen-5-yl)-6,7-dihydroxy-coumarin; SCHEMBL18172254 |
C18H10O8 |
354.27 |
C1=CC(=O)OC2=C1C(=C(C(=C2)O)O)C3=C(C(=CC4=C3C=CC(=O)O4)O)O |
TCMBANKIN059117 |
24-Methyl enecyclo artanone |
24-methylene cycloartanone |
C31H50O |
438.7 g/mol |
CC(C)C(=C)CCC(C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(=O)C5(C)C)C)C |
TCMBANKIN059638 |
glutinol |
|
C30H50O |
426.72 |
CC1(CCC2(CCC3(C4CC=C5C(C4(CCC3(C2C1)C)C)CCC(C5(C)C)O)C)C)C |
TCMBANKIN005212 |
Proliferin C |
|
C38H48O13 |
712.8 g/mol |
CCC(=O)OC1C(CC2(C1C(C34COC(C3C(C=CC4OC(=O)C)C(C)(C)OC(=O)C)(C2OC(=O)C5=CC=CC=C5)C)OC(=O)C)OC(=O)C)C |
TCMBANKIN008050 |
Proliferin A |
|
C42H54O15 |
798.9 g/mol |
CCC(=O)OC1C2C(C34COC(C3C(C=CC4OC(=O)C)C(C)(C)OC(=O)C)(C(C2(CC1(C)OC(=O)C(C)C)OC(=O)C)OC(=O)C5=CC=CC=C5)C)OC(=O)C |
TCMBANKIN011381 |
inokosterone |
Callinecdysone A; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1R,2R,5R)-1,2,6-trihydroxy-1,5-dimethyl-hexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; C16992; 15130-85-5; Inokosterone; i-nokosterone; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,6R)-2,3,7-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,6R)-2,3,7-trihydroxy-6-methyl-heptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1R,2R,5R)-1,2,6-trihydroxy-1,5-dimethylhexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; 23261-09-8; DTXSID30436277; C08819 |
C27H44O7 |
480.6 g/mol |
CC(CCC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O)CO |
TCMBANKIN013020 |
SPr5 |
|
C38H46O14 |
|
CCC(=O)OC1C(CC2(C1C(C34COC(C3C5C(CC5(C)OC(=O)C)C(C4=O)OC(=O)C6=CC=CC=C6)(C2OC(=O)C)C)OC(=O)C)OC(=O)C)C |
TCMBANKIN013989 |
Euphorprolitherin B |
|
C40H50O15 |
770.8 g/mol |
CCC(=O)OC1C2C(C34COC(C3C(C=CC4OC(=O)C)C(C)(C)OC(=O)C)(C(C2(CC1(C)OC(=O)C)OC(=O)C)OC(=O)C5=CC=CC=C5)C)OC(=O)C |
TCMBANKIN015744 |
ingenol |
|
C20H28O5 |
348.43 |
CC1CC2C(C2(C)C)C3C=C(C(C4(C1(C3=O)C=C(C4O)C)O)O)CO |
TCMBANKIN021323 |
6-tritriacontanol |
|
C33H68O |
480.9 g/mol |
CCCCCCCCCCCCCCCCCCCCCCCCCCCC(CCCCC)O |
TCMBANKIN024147 |
Euphorprolitherin D |
|
|
|
|
TCMBANKIN029747 |
Proliferin D |
|
C41H46O13 |
746.8 g/mol |
CCC(=O)OC1C(CC2(C1C(C34COC(C3C5C(CC5(C)OC(=O)C)C(C4=O)OC(=O)C6=CC=CC=C6)(C2OC(=O)C7=CC=CC=C7)C)OC(=O)C)O)C |
TCMBANKIN035196 |
Proliferin B |
|
C45H52O15 |
832.9 g/mol |
CCC(=O)OC1C2C(C34COC(C3C(C=CC4OC(=O)C)C(C)(C)OC(=O)C)(C(C2(CC1(C)OC(=O)C5=CC=CC=C5)OC(=O)C)OC(=O)C6=CC=CC=C6)C)OC(=O)C |
TCMBANKIN036389 |
14-desoxo-3-O- prorionyl-5,15-di-O-acetyl-7-O-nicotinoyl-myrsinol-14β-acetate |
|
C36H44O11 |
|
CCC(=O)OC1C(CC2(C1C(C34COC(C3C(C=CC4OC(=O)C5=CC=CC=C5)C(=C)C)(C2OC(=O)C)C)OC(=O)C)OC(=O)C)C |
TCMBANKIN038365 |
Ingenol-3,20-dibenzoate |
ingenol 3,20-dibenzoate |
|
556.65 |
|
TCMBANKIN038394 |
Keampferol-3-O-lysimachiatrioside |
|
C35H40O19 |
|
c1([H])c(O[H])c(C(=O)C(O[C@]([H])([C@@]([H])(C([H])=O)[C@]([H])(C([H])=O)[C@@]2([H])O[C@@]3([H])[C@@]([H])(C([H])([H])O[H])O[C@]([H])(O[C@@]4([H])[C@@]([H])(C([H])([H])[H])O[C@@]([H])(O[H])[C@]([H])(O
[H])[C@@]4([H])O[H])[C@@]([H])(O[H])[C@@]3([H])O[H])[C@]([H])(C([H])([H])[H])O2)=C(c5c([H])c([H])c(O[H])c([H])c5[H])O6)c6c([H])c1O[H] |
TCMBANKIN045994 |
tritriacontanol |
CTK0G2974; Tritriacontane-1-ol; 1-Tritriacontanol; SCHEMBL810872; LMFA05000604; DTXSID00221556; 71353-61-2; tritriacontan-1-ol; ACMC-1BFS4; 107602-36-8; AC1L4FN0; n-tritriacontanol |
C33H68O |
480.9 g/mol |
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO |
TCMBANKIN048485 |
Kaempferol-3-β-D-glucuronide |
|
|
|
|
TCMBANKIN059117 |
24-Methyl enecyclo artanone |
24-methylene cycloartanone |
C31H50O |
438.7 g/mol |
CC(C)C(=C)CCC(C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(=O)C5(C)C)C)C |
TCMBANKIN061144 |
n-tritriacontane |
|
C33H68 |
464.9 g/mol |
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC |